APA (7th ed.) Citation

Park, H., Matsuoka, Y., Santos, C., Luongo, C., Liu, X., Yang, L., . . . Le Nouën, C. (2025). Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challenge. PLoS Pathogens, 21(4), 1. https://doi.org/10.1371/journal.ppat.1012585

Chicago Style (17th ed.) Citation

Park, Hong-Su, et al. "Intranasal Parainfluenza Virus-vectored Vaccine Expressing SARS-CoV-2 Spike Protein of Delta or Omicron B.1.1.529 Induces Mucosal and Systemic Immunity and Protects Hamsters Against Homologous and Heterologous Challenge." PLoS Pathogens 21, no. 4 (2025): 1. https://doi.org/10.1371/journal.ppat.1012585.

MLA (9th ed.) Citation

Park, Hong-Su, et al. "Intranasal Parainfluenza Virus-vectored Vaccine Expressing SARS-CoV-2 Spike Protein of Delta or Omicron B.1.1.529 Induces Mucosal and Systemic Immunity and Protects Hamsters Against Homologous and Heterologous Challenge." PLoS Pathogens, vol. 21, no. 4, 2025, p. 1, https://doi.org/10.1371/journal.ppat.1012585.